Advanced search
Publication Cover
Journal of Medical Economics Volume 20, 2017 - Issue 2
Submit an article Journal homepage
853
Views
12
CrossRef citations to date
0
Altmetric
Cardiovascular

Healthcare costs associated with rivaroxaban or warfarin use for the treatment of venous thromboembolism

Craig I. ColemanUniversity of Connecticut School of Pharmacy, Storrs, CT, USA; Correspondence[email protected]
,
Christopher BaughBrigham & Women’s Hospital and Harvard Medical School, Boston, MA, USA;
,
Concetta CriveraJanssen Scientific Affairs, LLC, Raritan, NJ, USA;
,
Dejan MilentijevicJanssen Scientific Affairs, LLC, Raritan, NJ, USA;
,
Sheng-Wei WangJanssen Research and Development, LLC, Raritan, NJ, USA
,
Lang LuJanssen Research and Development, LLC, Raritan, NJ, USA
&
Winnie W. NelsonJanssen Scientific Affairs, LLC, Raritan, NJ, USA;
show all
Pages 200-203 | Received 15 Jul 2016, Accepted 16 Aug 2016, Published online: 26 Oct 2016

Citations (12)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Jeffrey Trocio, Virginia M Rosen, Anu Gupta, Oluwaseyi Dina, Lien Vo, Patrick Hlavacek & Lisa Rosenblatt. (2019) Systematic literature review of treatment patterns for venous thromboembolism patients during transitions from inpatient to post-discharge settings. ClinicoEconomics and Outcomes Research 11, pages 23-49.
Read now
Michael Streiff, Dejan Milentijevic, Keith R. McCrae, François Laliberté, Dominique Lejeune, Patrick Lefebvre, Jeff Schein & Alok A. Khorana. (2019) Healthcare resource utilization and costs associated with venous thromboembolism in cancer patients treated with anticoagulants. Journal of Medical Economics 22:11, pages 1134-1140.
Read now
Christine G. Kohn, Gregory J. Fermann, W. Frank Peacock, Phil S. Wells, Christopher W. Baugh, Veronica Ashton, Concetta Crivera, Jeff R. Schein, Peter Wildgoose & Craig I. Coleman. (2017) Association between rivaroxaban use and length of hospital stay, treatment costs and early outcomes in patients with pulmonary embolism: a systematic review of real-world studies. Current Medical Research and Opinion 33:9, pages 1697-1703.
Read now

Articles from other publishers (9)

Haneen Amawi, Rasha M. Arabyat, Sayer Al-Azzam, Toqa AlZu’bi, Hamza Tayseer U’wais, Alaa M. Hammad, Ruba Amawi & Mohammad B. Nusair. (2023) The Length of Hospital Stay of Patients with Venous Thromboembolism: A Cross-Sectional Study from Jordan. Medicina 59:4, pages 727.
Crossref
Ka-Po Fung, Kei-Hong Chan, Vivien Ng, Ping-Tim Tsui & Joyce H. S. You. (2019) Health Economic Analysis of Rivaroxaban and Warfarin for Venous Thromboembolism Management in Chinese Patients. Cardiovascular Drugs and Therapy 33:3, pages 331-337.
Crossref
Craig I. Coleman, Alexander G.G. Turpie, Thomas J. Bunz, Jan Beyer-Westendorf & William L. Baker. (2019) Impact of Prolonged Anticoagulation with Rivaroxaban on Provoked Venous Thromboembolism Recurrence: IMPROVE-VTE. The American Journal of Medicine 132:4, pages 498-504.
Crossref
Craig I. Coleman, Alexander G. G. Turpie, Thomas J. Bunz & Jan Beyer-Westendorf. (2018) Effectiveness and safety of rivaroxaban versus warfarin in patients with provoked venous thromboembolism. Journal of Thrombosis and Thrombolysis 46:3, pages 339-345.
Crossref
Craig I. Coleman, W. Frank Peacock, Thomas J. Bunz & Jan Beyer-Westendorf. (2018) Effectiveness and safety of rivaroxaban versus warfarin in patients with unprovoked venous thromboembolism: A propensity-score weighted administrative claims cohort study. Thrombosis Research 168, pages 31-36.
Crossref
Jan Beyer-Westendorf. (2018) What have we learned from real-world NOAC studies in venous thromboembolism treatment?. Thrombosis Research 163, pages 83-91.
Crossref
Amanda N. Basto, Nathan P. Fewel, Kim Vo, Eileen M. Stock & Mia Ta. (2017) Initiation of direct oral anticoagulants versus warfarin for venous thromboembolism: impact on time to hospital discharge. Journal of Thrombosis and Thrombolysis 45:1, pages 51-55.
Crossref
Julia Czuprynska, Jignesh P. Patel & Roopen Arya. (2017) Current challenges and future prospects in oral anticoagulant therapy. British Journal of Haematology 178:6, pages 838-851.
Crossref
Craig I. Coleman, Thomas J. Bunz & Alexander G. G. Turpie. (2017) Effectiveness and safety of rivaroxaban versus warfarin for treatment and prevention of recurrence of venous thromboembolism. Thrombosis and Haemostasis 117:10, pages 1841-1847.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.